Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Prothena Corporation PLC (NASDAQ:PRTA)

31.51
Delayed Data
As of Feb 12
 +1.39 / +4.61%
Today’s Change
21.23
Today|||52-Week Range
76.42
-53.74%
Year-to-Date

Today’s Trading

Previous close30.12
Today’s open31.02
Day’s range29.49 - 31.95
Volume599,691
Average volume (3 months)467,662
Market cap$1.1B
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+86.82%
Earnings growth (this year)--
Earnings growth (next 5 years)-134.72%
Revenue growth (last year)+7,422.78%
P/E ratioNM
Price/Sales10.07
Price/Book2.98

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...+1.39+4.53%
ITCIIntra-Cellular Thera...-0.42-1.58%
GWPHGW Pharmaceuticals P...+0.44+1.00%
TXMDTherapeuticsMD Inc-0.05-0.81%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateFebruary 19, 2016
EPS forecast (this quarter)-$0.81
Annual revenue (last year)$50.9M
Annual profit (last year)-$7.2M
Net profit margin-14.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Dale B. Schenk
Chief Financial Officer &
Head-Investor Relations
Tran B. Nguyen
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers